CEPR Claims Curo Wasn't Sold to CDR

Strange Tony,

The Center for Economic Policy and Research issued a report "Preying on the Dying:  Private Equity Gets Rich in Hospice Care."  I am grateful for their report as it highlights many concerns shared on Generic Hospice.

They detail the history I lived as part of a Kindred/Kindred at Home/Gentiva hospice team.  Their report states:

Curo was not part of this divestiture to CD&R but was also rebranded under Gentiva while remaining under the majority ownership of Humana.

I have found no evidence to support this assertion.  If Humana kept majority ownership of Curo the company would be shown on their list of subsidiaries filed with the SEC.  It is not.  

Humana declared a number of Curo and Gentiva subsidiaries after buying out financial rapscallions TPG and WCAS.  Those subs disappeared from Humana's list after they did the deal with rapscallion Clayton, Dubilier and Rice.

I wrote CEPR with this concern but have yet to hear anything back.  If they have a better source indicating current Curo ownership I'd love to see it.

Humana adopted the Curo operating model when they snatched Kindred at Home from Kindred Healthcare.  The PE Stakeholder Project confused this history in their report.  I submitted a correction to them as well but have seen no change in their report.

Curo has a special place in my emotional store of unfair treatment.  Executives gave us their bad systems, miserly staffing model and abject indifference to unique items that made our hospice care special.   Mooresville, North Carolina became the place we dealt with for HR issues and spent hours on hold multiple times a week trying to get help from IT.

I wish Humana separated us from Curo a long time ago, but that never happened.  I want CEPR to have their facts right so their report can have more impact.  Even in the murky world of financial rapscallions facts can eventually become clear.

Anonymous